ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1316

Frail Patients Have Less Pain After Total Hip Replacement

Lisa Mandl1, Charles Cornell 1, Michael Cross 1, Alejandro Gonzalez Della Valle 1, Mark Figgie 1, Seth Jerabek 1, Marianna Frey 2, John Roberts IV 3, Justin Do 3, Mayu Sasaki 3, Nathaniel Hupert 4, Jackie Finik 3 and Steven Magid 1, 1Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, New York, NY, 2Hospital for Special Surgery, New York, NY, New York, 3Hospital for Special Surgery, New York, NY, New York, NY, 4Weill Cornell Medicine, New York, NY, New York, NY

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: frailty, Osteoarthritis, patient outcomes and total joint replacement

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: Osteoarthritis – Clinical Poster I

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: To determine whether frailty is associated with patient outcomes 1 year after total hip replacement (THR).

Methods: Patients ≥65yo scheduled for elective primary THR for osteoarthritis were recruited from a musculoskeletal specialty hospital. All were approved for surgery by an internist. Frailty was defined using composite criteria designed for surgical candidates, evaluated at point of care. Hip Injury and Osteoarthritis Outcome Score (HOOS) and PROMIS29 were administered pre-operatively and at 1-year. Depression was measured using the Center for Epidemiologic Studies Depression Scale (CES-D 10). A subset of patients had frailty assessed by their surgeon pre-operatively using the brief, self-report Clinical Frailty Scale for Physicians. Wilcoxon rank-sum and Fisher’s exact tests were used to compare continuous variables and categorical variables, respectively, across frailty status. Multivariable linear and logistic regressions were modeled for each patient-related outcome, adjusting for confounders identified a priori using a directed acyclic graph approach. Spearman correlation coefficients were calculated to evaluate the correlation between frail scales.

Results: 332 hip replacement subjects enrolled, 9% of whom were frail. Frail THR subjects were older, more likely to be depressed, have concurrent back pain, and were also more likely to have had a previous hip or knee replacement. 91.4% provided 1-year follow-up. In a multivariable linear regression controlling for age, gender, race, back pain, education, Charlson comorbidity index, and PROMIS29 anxiety and depression, frailty predicted a clinically meaningful improvement in HOOS pain (β=10.4), which was statistically significant (p=0.01). Frailty also predicted a significant decrease in PROMIS pain interference T-score at 1-year, (β=3.9; p-value 0.023), controlling for the same potential confounders. Frailty did not predict other HOOS subscales or PROMIS29 domains at 1-year. Frailty did not predict cumulative severe adverse events through 1 year or OMERACT-OARSI responder status at 1-year. There was a strong correlation between our frailty definition and the Fried frailty phenotype, (r=0.79; p< 0.001), but a poor correlation with the orthopedic surgeon’s frailty assessment (r=0.16; p=0.78).

Conclusion: Frailty was a strong predictor of less hip-related pain and less overall pain interference 1 year after THR in older adults undergoing elective primary THR. Frailty was not associated with odds of adverse events or OMERACT-OARSI responder status. Surgeon assessment of frailty is not an accurate proxy for the frailty phenotype. Appropriately screened frail patients should not be discouraged from having THR for pain relief, particularly given the known risks of long term NSAIDS and narcotics. These data can aid in surgical decision making for frail patients contemplating THR.


AAOS.2020.Hips.Frailty.Table


Disclosure: L. Mandl, Annals of Internal Medicine, 3, Annals of Internal Medicine- Associate Editor, 3, UpToDate, 7, Wolters Kluwer - Author at UptoDate, 7, Wolters Kluwer - Author at UpToDate, 7, Wolters Kluwer- Author at UpToDate, 7; C. Cornell, None; M. Cross, Acelity, 2, 5, 8, Bone and Joint Journal 360, 6, Depuy, 5, Exactech, Inc., 2, 5, Flexion Therapeutics, 5, 8, Imagen, 4, Insight Medical, 4, Intellijoint, 2, 4, 5, Journal of Orthopaedics and Traumatology, 6, Parvizi Surgical Innovation, 4, Smith + Nephew, 5, Techniques in Orthopaedics, 6, Zimmer, 5; A. Gonzalez Della Valle, Intellijoint Surgical, 2, 5, Link Orthopaedics, 5, OrthoDevelopment, 5, 7, Orthosensor, 5, 7; M. Figgie, Insight, 4, Lima, 7, Mekanika, 4, Wishbone, 4, 5, 7; S. Jerabek, Imagen, LLC, 4, Stryker Orthopaedics, 5, 7; M. Frey, None; J. Roberts IV, None; J. Do, None; M. Sasaki, None; N. Hupert, None; J. Finik, None; S. Magid, None.

To cite this abstract in AMA style:

Mandl L, Cornell C, Cross M, Gonzalez Della Valle A, Figgie M, Jerabek S, Frey M, Roberts IV J, Do J, Sasaki M, Hupert N, Finik J, Magid S. Frail Patients Have Less Pain After Total Hip Replacement [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/frail-patients-have-less-pain-after-total-hip-replacement/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/frail-patients-have-less-pain-after-total-hip-replacement/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology